Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-01-01 @ 6:58 PM
Study NCT ID:
NCT00849251
Status:
TERMINATED
Last Update Posted:
2017-09-08
First Post:
2009-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-20
First Submit QC Date:
None
Study First Post Date:
2009-02-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-04
Results First Submit QC Date:
None
Results First Post Date:
2017-09-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-07
Last Update Post Date:
2017-09-08
Last Update Post Date Type:
ACTUAL